-3.64%
8.16%
9.66%
-27.40%
-55.21%
-65.58%
-82.23%
AI Spotlight on NEPH
Company Description
Nephros, Inc.develops and sells high performance water solutions to the medical and commercial markets in the United States.The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products.
It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease.In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets.
The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Market Data
| Last Price | 1.59 |
| Change Percentage | -3.64% |
| Open | 1.67 |
| Previous Close | 1.65 |
| Market Cap ( Millions) | 17 |
| Volume | 10477 |
| Year High | 3.83 |
| Year Low | 1.36 |
| M A 50 | 1.56 |
| M A 200 | 1.85 |
Financial Ratios
| FCF Yield | -12.90% |
| Dividend Yield | 0.00% |
| ROE | -11.39% |
| Debt / Equity | 18.25% |
| Net Debt / EBIDTA | 128.32% |
| Price To Book | 2.05 |
| Price Earnings Ratio | -18.05 |
| Price To FCF | -7.75 |
| Price To sales | 1.24 |
| EV / EBITDA | -21.01 |
News
- Dec -04 - Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC
- Nov -09 - Nephros, Inc. (NEPH) Q3 2024 Earnings Call Transcript
- Oct -31 - Nephros Schedules Third Quarter 2024 Financial Results Conference Call
- Oct -17 - Nephros Delivers Critical Disaster Response to Support Hospitals and Care Facilities Impacted by Hurricanes Helene and Milton
- Aug -10 - Nephros, Inc. (NEPH) Q2 2024 Earnings Call Transcript
- Aug -08 - Nephros Announces Financial Results for Quarter Ended June 30, 2024
- Aug -01 - Nephros Schedules Second Quarter 2024 Financial Results Conference Call
- Mar -08 - Nephros, Inc. (NEPH) Q4 2023 Earnings Call Transcript
- Mar -07 - Nephros Announces Fourth Quarter and Fiscal Year 2023 Financial Results
- Feb -29 - Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
- Nov -10 - Nephros, Inc. (NEPH) Q3 2023 Earnings Call Transcript
- Nov -08 - Nephros Announces Results for Quarter Ended September 30, 2023
- Nov -01 - Nephros Hires Judy Krandel as Chief Financial Officer
- Oct -25 - Nephros Schedules Third Quarter 2023 Financial Results Conference Call
- Sep -19 - Nephros to Present at LD Micro Main Event XVI
- Aug -10 - Nephros, Inc. (NEPH) Q2 2023 Earnings Call Transcript
- Aug -09 - Nephros Announces Results for Quarter Ended June 30, 2023
- Jul -26 - Nephros Schedules Second Quarter 2023 Financial Results Conference Call
- May -24 - Nephros to Present at LD Micro Invitational XIII
- Apr -26 - Nephros Schedules First Quarter 2023 Financial Results Conference Call
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Water Filtration
Expected Growth : 10.2 %
What the company do ?
Nephros' water filtration systems provide high-quality, portable, and easy-to-use solutions for removing contaminants and impurities from water, ensuring safe and clean drinking water.
Why we expect these perspectives ?
Growing demand for clean drinking water, increasing awareness of waterborne diseases, and advancements in water filtration technology drive the growth of Nephros' water filtration systems.
Segment n°2 -> Other
Expected Growth : 10.2 %
What the company do ?
Nephros, Inc.'s 'Other' segment includes sales of water filtration products, including those used in medical, commercial, and industrial applications.
Why we expect these perspectives ?
Growing demand for clean water, increasing adoption in medical and industrial applications, and expanding product offerings drive growth in Nephros' 'Other' segment, which includes water filtration products.
Segment n°3 -> Royalty
Expected Growth : 10.2 %
What the company do ?
Nephros, Inc. royalty refers to the payment made to the company for the use of its proprietary water filtration systems and products by other companies.
Why we expect these perspectives ?
Increasing demand for clean water, growing adoption of water filtration systems in healthcare and industrial applications, and Nephros' proprietary technology are expected to drive royalty revenue growth.
Nephros, Inc. Products
| Product Range | What is it ? |
|---|---|
| Ultrafiltration Products | Nephros' ultrafiltration products are designed to provide high-quality water purification for various industries, including medical, industrial, and commercial applications. |
| Dialysis Water Purification Systems | Nephros' dialysis water purification systems are designed to provide high-quality water for hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. |
| Hydration Systems | Nephros' hydration systems are designed to provide clean drinking water for various applications, including military, outdoor, and emergency response situations. |
| Pathogen Detection Systems | Nephros' pathogen detection systems are designed to detect and identify waterborne pathogens, including bacteria, viruses, and parasites. |
| Water Filtration Systems | Nephros' water filtration systems are designed to provide clean drinking water for various applications, including residential, commercial, and industrial use. |
Nephros, Inc.'s Porter Forces
Threat Of Substitutes
Nephros, Inc. faces moderate threat from substitutes due to the availability of alternative water filtration systems.
Bargaining Power Of Customers
Nephros, Inc. has a diverse customer base, which reduces the bargaining power of individual customers.
Bargaining Power Of Suppliers
Nephros, Inc. relies on a few key suppliers for its filtration systems, giving them moderate bargaining power.
Threat Of New Entrants
The water filtration industry is attractive, and new entrants may pose a significant threat to Nephros, Inc.'s market share.
Intensity Of Rivalry
The water filtration industry is highly competitive, with several established players, leading to a high intensity of rivalry.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 18.01% |
| Debt Cost | 3.95% |
| Equity Weight | 81.99% |
| Equity Cost | 10.12% |
| WACC | 9.01% |
| Leverage | 21.97% |
Nephros, Inc. : Quality Control
Nephros, Inc. passed 6 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| OSUR | OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in … |
| PDEX | Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that … |
| WRBY | Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and … |
| LMAT | LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing … |
| UTMD | Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
LeMaitre Vascular
A-Score
1-Year Total Return ->
🥈
Utah Medical Products
A-Score
1-Year Total Return ->
🥉
Pro-Dex
A-Score
1-Year Total Return ->
4
Warby Parker
A-Score
1-Year Total Return ->
5
OraSure Technologies
A-Score
1-Year Total Return ->
6
